Overview

Prophylactic Treatment of Episodic Cluster Headache

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether candesartan cilexetil are effective prophylactic treatment of episodic Cluster headache
Phase:
Phase 2
Details
Lead Sponsor:
Norwegian University of Science and Technology
Collaborator:
AstraZeneca
Treatments:
Angiotensin II
Angiotensin Receptor Antagonists
Angiotensinogen
Candesartan
Candesartan cilexetil